Search research articles
Contact Us
Filters
Showing results (11-20 of 84) with videos related to
Page
of 9
Sort By:
Redox Biology
|
October 8, 2018
The enzyme activity of histone deacetylase 8 is modulated by a redox-switch
Niklas Jänsch, Christian Meyners, Marius Muth, et al.
International Journal of Cancer
|
October 2, 2012
HDAC11 is a novel drug target in carcinomas
Hedwig E Deubzer, Marie C Schier, Ina Oehme, et al.
Journal of Medicinal Chemistry
|
December 15, 2015
Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors
Johanna Senger, Jelena Melesina, Martin Marek, et al.
Future Medicinal Chemistry
|
August 31, 2016
Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases
Alokta Chakrabarti, Jelena Melesina, Fiona R Kolbinger, et al.
Trends in Pharmacological Sciences
|
May 28, 2015
HDAC8: a multifaceted target for therapeutic interventions
Alokta Chakrabarti, Ina Oehme, Olaf Witt, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2022
Synthesis, Biochemical, and Cellular Evaluation of HDAC6 Targeting Proteolysis Targeting Chimeras
Salma Darwish, Tino Heimburg, Johannes Ridinger, et al.
FEBS Open Bio
|
June 26, 2025
Phenotypic plasticity in a novel set of EGFR tyrosine kinase inhibitor-adapted non-small cell lung cancer cell lines
Tharsagini V Nanthaprakash, Campbell W Gourlay, Ina Oehme, et al.
BMC Cancer
|
June 12, 2012
Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer
Dmitriy I Dovzhanskiy, Stefanie M Arnold, Thilo Hackert, et al.
Blood
|
June 27, 2013
Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells
Nathalie Fiegler, Sonja Textor, Annette Arnold, et al.
European Journal of Medicinal Chemistry
|
October 21, 2019
Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors
Benjamin Wolff, Niklas Jänsch, Wisely Oki Sugiarto, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 84) with videos related to
Sort By:
Page
of 9
Redox Biology
|
October 8, 2018
The enzyme activity of histone deacetylase 8 is modulated by a redox-switch
Niklas Jänsch, Christian Meyners, Marius Muth, et al.
International Journal of Cancer
|
October 2, 2012
HDAC11 is a novel drug target in carcinomas
Hedwig E Deubzer, Marie C Schier, Ina Oehme, et al.
Journal of Medicinal Chemistry
|
December 15, 2015
Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors
Johanna Senger, Jelena Melesina, Martin Marek, et al.
Future Medicinal Chemistry
|
August 31, 2016
Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases
Alokta Chakrabarti, Jelena Melesina, Fiona R Kolbinger, et al.
Trends in Pharmacological Sciences
|
May 28, 2015
HDAC8: a multifaceted target for therapeutic interventions
Alokta Chakrabarti, Ina Oehme, Olaf Witt, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2022
Synthesis, Biochemical, and Cellular Evaluation of HDAC6 Targeting Proteolysis Targeting Chimeras
Salma Darwish, Tino Heimburg, Johannes Ridinger, et al.
FEBS Open Bio
|
June 26, 2025
Phenotypic plasticity in a novel set of EGFR tyrosine kinase inhibitor-adapted non-small cell lung cancer cell lines
Tharsagini V Nanthaprakash, Campbell W Gourlay, Ina Oehme, et al.
BMC Cancer
|
June 12, 2012
Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer
Dmitriy I Dovzhanskiy, Stefanie M Arnold, Thilo Hackert, et al.
Blood
|
June 27, 2013
Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells
Nathalie Fiegler, Sonja Textor, Annette Arnold, et al.
European Journal of Medicinal Chemistry
|
October 21, 2019
Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors
Benjamin Wolff, Niklas Jänsch, Wisely Oki Sugiarto, et al.
Page
of 9